Tetraneuron

A new path for Alzheimer’s Disease

[Tetraneuron @tetraneuron]

Our Disease-Modifying #genetherapy reduces amyloid pathology, neuroinflammation, cell dead and rescues synaptic plasticity and memory. Don’t miss posters 142&147! We will be there today to discuss about new advances and future perspectives.#AAIC23 #ENDALZ @ISTAART #Alzheimers

[Tetraneuron @tetraneuron]

We are really pleased to announce that TETRANEURON has received positive feedback from the FDA during the pre-IND meeting, supporting our approach for our #genetherapy TET-101 for Alzheimer's Disease.

We are incredibly proud of our team!

[Tetraneuron @tetraneuron]

Alzhéimer: "Hay que hacer parada en boxes para ganar la carrera de la salud cerebral" https://t.co/hJLtBK00h5

[Howard Fillit, MD @a_hfillit]

Interesting article by @RitaRubin highlighting the need to look beyond #amyloid to a more holistic approach for developing #Alzheimers therapies guided by the #BiologyofAging. @TheADDF is laser-focused on cultivating a diverse pipeline https://t.co/tSYmSMS2E5 @JAMA_current

[Tetraneuron @tetraneuron]

To deal with Alzheimer's disease, multifactorial therapies must be investigated. We need to take into account all the altered processes in the brain of patients who develop the disease.

Thanks' to @elEconomistaes for sharing our message

https://t.co/ReaJimjWpJ

[Tetraneuron @tetraneuron]

Today we are participating in a Human Brain Project workshop. Thank you very much to the Polytechnical University of Madrid for inviting us!

https://t.co/1HV8eFc5wk

[Tetraneuron @tetraneuron]

Tomorrow morning you will have the opportunity to discuss with @csanchezpuelles (247) and @Morgan7lan (248) about the multifactorial gene therapy for #Alzheimers disease effect on cognition, synaptic plasticity, cell death and neuroinflamation. #FENS2022 #biotech #clinicaltrial

[Tetraneuron @tetraneuron]

Tetraneuron team @csanchezpuelles and @Morgan7lan in the #FENS2022
Lots of amazing #neuroscience these days! #Alzheimers #genetherapy #invest

[Tetraneuron @tetraneuron]

📢 New interview with Jose Maria Frade. Do not miss it!
https://t.co/POC1LIo3ut

[Tetraneuron @tetraneuron]

Did you miss our Demo Day? Contact us for the information!
➡️[email protected]

https://t.co/zoez7qSju7

[EFEsalud @efesalud]

¿Cómo prevenir y abordar el desgaste físico, psíquico, emocional y el riesgo de aislamiento social de los cuidadores al cargo de personas con #demencia ?

Manual de la Confederación Española de Alzhéimer @AlzheimerCeafa

https://t.co/0VrLHHtJJR

[Fundación Tatiana @fund_tatiana]

V Edición #YCL: Estamos muy orgullosos de vosotros! Gracias por elegirnos! #FundacionTatiana

[CEAFA @AlzheimerCeafa]

🗣Nuestro CEO, Jesús Rodrigo, continúa en la #ADI2022 de @AlzDisInt que se celebra hasta el día 11 en #Londres para ver el Plan de acción mundial de la @WHO.
Hoy modera la Plenaria 3 “Mes Mundial del #Alzheimer y Comunidades Amigas de la #Demencia: prioridades urgentes”

[Tetraneuron @tetraneuron]

Estamos orgullosos de anunciar la incorporación de Álvaro Pascual Leone a nuestro Scientific Advisory Board. El Dr. Pascual-Leone ha sido reconocido como uno de los 15 neurocientíficos más relevantes del mundo. ¡Bienvenido Álvaro!
https://t.co/MHXPXM4D0G

[Tetraneuron @tetraneuron]

¿Quieres conocer mejor a nuestro Director Científico @jmfradelopez ? No te pierdas la entrevista que le hizo @JALGUERRERO en Entre Probetas de @rtve

#Alzheimer #genetherapy #Tetraneuron

[Tetraneuron @tetraneuron]

Ya somos parte de @BIOVAL_es! Estamos encantados de formar parte de este importante cluster biotecnológico.

#BioVal #Tetraneuron #alzheimer #genetherapy

https://t.co/N6NmZsKVnb

[Tetraneuron @tetraneuron]

Tetraneuron celebra su Demo Day. Te esperamos!

Inscríbete aquí:
https://t.co/N1f3yOFZ3w

[Tetraneuron @tetraneuron]

Por fin os dejamos el vídeo de nuestra participación en el programa Emprende de @rtve . Estamos encantados de la colaboración👇

https://t.co/Gz3ExJapoZ

[Tetraneuron @tetraneuron]

TETRANEURON will be in London at the 8th LSX World Congress #LSXleaders

If you are interested in investing in an innovative gene therapy for Alzheimer's Disease, reach out to schedule a 1:1 meeting with M.Carmen Alvarez Abril & David Mor

https://t.co/Ltig2bYOK2

[Tetraneuron @tetraneuron]

Gracias @nmeconomics por compartir este interesante artículo de nuestro Director Científico @jmfradelopez

https://t.co/kfLRLS37rr

#Tetraneuron